R&D Systems Inc. Tocris Bioscience Boston Biochem

Cell Cycle Inhibitors

Cell cycle inhibitors slow or stop cell cycle progression through various mechanisms. Cell cycle arrest can be induced at different stages, decreasing the rate of cell division and the number of actively cycling cells.

Cell Cycle Inhibitor Products

 
Cat.No.
Product Name / Activity
4138 ABT 751
Inhibitor of microtubule polymerization; blocks cell cycle at G2M
3968 AZD 5438
Blocks cell cycling at G2-M, S and G1 phases
1761 Baicalein
Induces G1 and G2 cell cycle arrest. Also lipoxygenase inhibitor
4436 8-Chloroadenosine
Cytotoxic nucleoside analog; induces G2/M arrest
2039 CI 898 trihydrochloride
Antineoplastic agent; affects G1/S phase progression
1417 Daidzein
Arrests cell cycle in G1 phase
4502 DIM
Activates Chk2; induces G2/M cell cycle arrest
3502 Epothilone B
Microtubule stabilization agent; promotes G2-M cell cycle arrest
1813 Indirubin-3'-oxime
Induces cell cycle arrest, antiproliferative
1230 Methotrexate
Cytotoxic agent
3715 Narciclasine
Antiproliferative agent; slows cell cycle progression
4761 Plumbagin
Induces G2/M cell cycle arrest; anticancer
4817 SKPin C1
Inhibits Skp2-mediated p27 degradation; induces cell cycle arrest
4282 WYE 687 dihydrochloride
Potent and selective mTOR inhibitor; induces G1 cell cycle arrest

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Guide

Request your free copy

Cancer Research Guide

Highlights over 350 products for cancer research. Request a copy or view PDF today.

divider line

Checkpoint Kinases & the DNA Damage Response

Written by Michelle D. Garrett and Ian Collins

Cell Cycle Kinases Poster

A summary of the response of the checkpoint kinase signaling network to DNA damage, including activation of DNA repair, cell-cycle arrest, senescence and apoptosis.

divider line

New Product Guide

NPG

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

divider line

20% Discount*

Potent, selective LRRK2 inhibitor

Potent LRRK2 inhibitor now available from Tocris Bioscience

Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

* Terms & conditions